Gene · 3274
Papers2,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Parkinsonism Attenuation by Antihistamines via Downregulating the Oxidative Stress, Histamine, and Inflammation. | ACS Omega | 2022 | 35557705 | PubTator, text mining | PubMed |
| Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells. | Front Pharmacol | 2022 | 35548336 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus. | Biosci Microbiota Food Health | 2022 | 35433161 | PubTator, text mining | PubMed |
| Barrier effect and wound healing activity of the medical device REF-FTP78 in the treatment of gastroesophageal reflux disease. | Sci Rep | 2022 | 35414705 | PubTator, text mining | PubMed |
| Relationship of histamine expression with chemokine balance in the tumor microenvironment of squamous cell carcinoma of the tongue. | Head Neck | 2022 | 35411649 | PubTator, text mining | PubMed |
| Targets Exploration of Hydroxychloroquine for Pigmentation and Cell Protection Effect in Melanocytes: The Clue for Vitiligo Treatment. | Drug Des Devel Ther | 2022 | 35411132 | PubTator, text mining | PubMed |
| Is Training With Gym Machines Safe After Hip Arthroplasty?-An In Vivo Load Investigation. | Front Bioeng Biotechnol | 2022 | 35402408 | PubTator, text mining | PubMed |
| Identification of potential target genes in Homo sapiens, by miRNA of Triticum aestivum: A cross kingdom computational approach. | Noncoding RNA Res | 2022 | 35387280 | PubTator, text mining | PubMed |
| DICE: Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian cancer resistant to standard treatment-a study protocol for a randomised trial investigating a novel therapy called TAK228. | Trials | 2022 | 35382842 | PubTator, text mining | PubMed |
| Activation of histamine type 2 receptors enhances intrinsic excitability of medium spiny neurons in the nucleus accumbens. | J Physiol | 2022 | 35343587 | PubTator, text mining | PubMed |
| Class A and C GPCR Dimers in Neurodegenerative Diseases. | Curr Neuropharmacol | 2022 | 35339177 | PubTator, text mining | PubMed |
| Mitigation of Gastric Damage Using Cinnamomum cassia Extract: Network Pharmacological Analysis of Active Compounds and Protection Effects in Rats. | Plants (Basel) | 2022 | 35336597 | PubTator, text mining | PubMed |
| Limosilactobacillus reuteri in Health and Disease. | Microorganisms | 2022 | 35336098 | PubTator, text mining | PubMed |
| Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document. | J Pers Med | 2022 | 35330468 | PubTator, text mining | PubMed |
| Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder. | Biomedicines | 2022 | 35327362 | PubTator, text mining | PubMed |
| "MATH+" Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale. | J Clin Med Res | 2022 | 35317360 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission. | J Allergy Clin Immunol | 2022 | 35304158 | PubTator, text mining | PubMed |
Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1). | J Evol Biochem Physiol | 2022 | 35283537 | PubTator, text mining | PubMed |
| A Computational Text Mining-Guided Meta-Analysis Approach to Identify Potential Xerostomia Drug Targets. | J Clin Med | 2022 | 35268532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3274/papers?page=15